CEO Massimiliano Colella delayed introducing the company’s soft tissue surgery system in the U.S. by a year but says the improved robot that is hitting the market now was worth the wait.

Add Yahoo as a preferred source to see more of our stories on Google. CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. (T.

CMR Surgical said Tuesday it received 510(k) clearance from the Food and Drug Administration for its next-generation robotic system to perform gallbladder removal procedures. The Cambridge, ...